You Searched For "psychedelic stocks" and got 20 results
Sort By:
The stock of psychedelics giant Atai is tumbling after a treatment failed to help patients in a trial
Atai Life Sciences' ketamine-based therapy failed to help patients with depression in a mid-stage t…
Sarah Braner  Â
Time to buy US cannabis stocks, analyst says
Welcome to Insider Cannabis, where we're bringing you an inside look at the deals, trends, and pers…
Jeremy Berke,Yeji Jesse Lee  Â
The first-ever psychedelics ETF will launch next week, backed by a Canadian fund manager
The Horizons Psychedelic Stock Index ETF (PSYK) will begin trading on the NEO exchange next Wednesd…
Emily Graffeo  Â
Peter Thiel-backed psychedelics company plans to raise $100 million in an IPO
Atai Life Sciences, a company that aims to use psychedelic compounds for therapeutic uses, is plann…
Emily Graffeo  Â
6 pot stocks to bet on now
Welcome to Insider Cannabis, where we're bringing you an inside look at the deals, trends, and pers…
Jeremy Berke,Yeji Jesse Lee  Â
Top psychedelic startups
Welcome to Insider Cannabis, where we're bringing you an inside look at the deals, trends, and pers…
Jeremy Berke,Yeji Jesse Lee  Â
Insider Cannabis: Stocks to bet on for New York legalization - Cannabis on Capitol Hill - Dutchie's $1.7 billion valuation
Welcome to Insider Cannabis, where we're bringing you an inside look at the deals, trends, and pers…
Jeremy Berke,Yeji Jesse Lee  Â
Psychedelic patent wars
Welcome to Insider Cannabis, where we're bringing you an inside look at the deals, trends, and pers…
Jeremy Berke,Yeji Jesse Lee  Â
A psychedelic renaissance
Welcome to Insider Cannabis, where we're bringing you an inside look at the deals, trends, and pers…
Jeremy Berke,Yeji Jesse Lee  Â
Here are Insider's biggest healthcare stories for November
These are Insider's biggest healthcare stories for the month of November.
Leah Rosenbaum  Â
The psychedelics company you've never heard of
Welcome to Insider Cannabis, where we're bringing you an inside look at the deals, trends, and pers…
Jeremy Berke,Yeji Jesse Lee  Â
Psychedelics renaissance
Welcome to Insider Cannabis, where we're bringing you an inside look at the deals, trends, and pers…
Jeremy Berke,Yeji Jesse Lee  Â
Civilized founders pushed out
Welcome to Insider Cannabis, where we're bringing you an inside look at the deals, trends, and pers…
Jeremy Berke,Yeji Jesse Lee  Â
Buy the dip, says Doug Kass
Welcome to Insider Cannabis, where we're bringing you an inside look at the deals, trends, and pers…
Jeremy Berke,Yeji Jesse Lee  Â
What to know about the booming psychedelics industry, where companies are racing to turn magic mushrooms and MDMA into approved medicines
Startups focused on turning psychedelic compounds into approved medicines have raised hundreds of m…
Yeji Jesse Lee  Â
Insider Cannabis: New York finally legalizes adult-use marijuana
Welcome to Insider Cannabis, where we're bringing you an inside look at the deals, trends, and pers…
Yeji Jesse Lee,Jeremy Berke  Â
New York's legalization deal
Welcome to Insider Cannabis, where we're bringing you an inside look at the deals, trends, and pers…
Jeremy Berke,Yeji Jesse Lee  Â
A magic mushroom firm backed by Peter Thiel is now worth $2 billion and reportedly eyeing an IPO
Atai Life Sciences recently raised $157 million in its Series D funding round, and reports say its …
Annabelle Williams  Â
New Jersey finally legalizes
Welcome to Insider Cannabis, where we're bringing you an inside look at the deals, trends, and pers…
Jeremy Berke,Yeji Jesse Lee  Â
Cannabis companies raised $1.4 billion in January
Welcome to Insider Cannabis, where we're bringing you an inside look at the deals, trends, and pers…